1d
Hosted on MSNMonoclonal Antibodies for Early Alzheimer's DiseaseEach episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
In 2022 the Supreme Court corrected a grave error and overturned Roe v. Wade. Many states quickly enacted laws to protect women and unborn children from abortion or allowed preexisting pro-life laws ...
Clinical validation of the Azymetric platform is demonstrated by the accelerated approval of Ziihera® (zanidatamab-hrii), a ...
Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...
GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.
Once a drug is approved, the specified equipment suppliers ... new modalities while the remainder comes from monoclonal antibodies. Repligen offers investors exposure to the rapidly growing ...
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
Kiniksa plans to initiate a Phase 2/3 clinical trial of KPL-387 in recurrent pericarditis in mid-2025 –– KPL-387 Phase 1 single ascending dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results